Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study

被引:27
作者
Atti, Ana [1 ]
Insalata, Ferdinando [1 ]
Carr, Edward J. [2 ]
Otter, Ashley D. [3 ]
Castillo-Olivares, Javier [4 ]
Wu, Mary [2 ]
Harvey, Ruth [2 ]
Howell, Michael [2 ]
Chan, Andrew [4 ]
Lyall, Jonathan [4 ]
Temperton, Nigel [5 ,6 ]
Cantoni, Diego [5 ,6 ]
da Costa, Kelly [5 ,6 ]
Nadesalingam, Angalee [4 ]
Taylor-Kerr, Andrew [1 ]
Hettiarachchi, Nipunadi [1 ]
Tranquillini, Caio [1 ]
Hewson, Jacqueline [3 ]
Cole, Michelle J. [1 ]
Foulkes, Sarah [1 ]
Munro, Katie [1 ]
Monk, Edward J. M. [1 ]
Milligan, Iain D. [1 ]
Linley, Ezra [7 ]
Chand, Meera A. [1 ]
Brown, Colin S. [1 ,8 ]
Islam, Jasmin [1 ]
Semper, Amanda [1 ]
Charlett, Andre [1 ,9 ,10 ]
Heeney, Jonathan L. [3 ]
Beale, Rupert [2 ]
Zambon, Maria [1 ]
Hopkins, Susan [1 ,8 ]
Brooks, Tim [1 ]
Hall, Victoria [1 ,8 ]
机构
[1] UK Hlth Secur Agcy, Smith Sq, London SW1P, England
[2] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England
[3] UK Hlth Secur Agcy, Salisbury SP4 0JG, Wilts, England
[4] Univ Cambridge, Dept Vet Med, Lab Viral Zoonot, Madingley Rd, Cambridge CB3 0ES, England
[5] Univ Greenwich, Medway Sch Pharm, Viral Pseudotype Unit, Cent Ave, Chatham ME4 4BF, Kent, England
[6] Univ Kent Medway, Medway Sch Pharm, Viral Pseudotype Unit, Cent Ave, Chatham ME4 4BF, Kent, England
[7] UK Hlth Secur Agcy, Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, Lancs, England
[8] Univ Oxford, Natl Inst Hlth Res, Hlth Protect Res NIHR Unit Healthcare Associated, Old Rd Campus, Oxford OX3 7BN, England
[9] Univ Bristol, NIHR Hlth Protect Res Unit Behav Sci & Evaluat, Publ Hlth England, Queens Rd, Bristol BS8 1QU, Avon, England
[10] London Sch Hyg & Trop Med, NIHR Hlth Protect Res Unit Immunisat, Publ Hlth England, Keppel St, London WC1E 7HT, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
SARS-CoV-2; Neutralising antibodies; serology; Reinfection; Immunity; HEALTH-CARE WORKERS; INFECTION; COHORT; VOCS;
D O I
10.1016/j.jinf.2022.09.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate serological differences between SARS-CoV-2 reinfection cases and contemporary controls, to identify antibody correlates of protection against reinfection.Methods: We performed a case-control study, comparing reinfection cases with singly infected individ-uals pre-vaccination, matched by gender, age, region and timing of first infection. Serum samples were tested for anti-SARS-CoV-2 spike (anti-S), anti-SARS-CoV-2 nucleocapsid (anti-N), live virus microneutral-isation (LV-N) and pseudovirus microneutralisation (PV-N). Results were analysed using fixed effect linear regression and fitted into conditional logistic regression models.Results: We identified 23 cases and 92 controls. First infections occurred before November 2020; re -infections occurred before February 2021, pre-vaccination. Anti-S levels, LV-N and PV-N titres were sig-nificantly lower among cases; no difference was found for anti-N levels. Increasing anti-S levels were associated with reduced risk of reinfection (OR 0 middot63, CI 0 middot47-0 middot85), but no association for anti-N levels (OR 0 middot88, CI 0 middot73-1 middot05). Titres > 40 were correlated with protection against reinfection for LV-N Wuhan (OR 0 middot02, CI 0 middot001-0 middot31) and LV-N Alpha (OR 0 middot07, CI 0 middot009-0 middot62). For PV-N, titres > 100 were associated with protection against Wuhan (OR 0 middot14, CI 0 middot03-0 middot64) and Alpha (0 middot06, CI 0 middot008-0 middot40).Conclusions: Before vaccination, protection against SARS-CoV-2 reinfection was directly correlated with anti-S levels, PV-N and LV-N titres, but not with anti-N levels. Detectable LV-N titres were sufficient for protection, whilst PV-N titres > 100 were required for a protective effect. Trial registration number: ISRCTN11041050Crown Copyright (c) 2022 Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:545 / 556
页数:12
相关论文
共 37 条
[1]   Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate [J].
Addetia, Amin ;
Crawford, Katharine H. D. ;
Dingens, Adam ;
Zhu, Haiying ;
Roychoudhury, Pavitra ;
Huang, Meei-Li ;
Jerome, Keith R. ;
Bloom, Jesse D. ;
Greninger, Alexander L. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (11)
[2]   Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study [J].
Atti, A. ;
Ferrari, M. ;
Castillo-Olivares, J. ;
Monk, E. J. M. ;
Gopal, R. ;
Patel, M. ;
Hoschler, K. ;
Cole, M. J. ;
Semper, A. ;
Hewson, J. ;
Otter, A. D. ;
Foulkes, S. ;
Islam, J. ;
Mirfenderesky, M. ;
Jain, S. ;
Murira, J. ;
Favager, C. ;
Nastouli, E. ;
Chand, M. A. ;
Brown, C. S. ;
Heeney, J. L. ;
Brooks, T. ;
Hall, V. J. ;
Hopkins, S. ;
Zambon, M. .
JOURNAL OF INFECTION, 2022, 84 (02) :252-254
[3]   Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds [J].
Cantoni, Diego ;
Mayora-Neto, Martin ;
Nadesalingam, Angalee ;
Wells, David A. ;
Carnell, George W. ;
Ohlendorf, Luis ;
Ferrari, Matteo ;
Palmer, Phil ;
Chan, Andrew C. Y. ;
Smith, Peter ;
Bentley, Emma M. ;
Einhauser, Sebastian ;
Wagner, Ralf ;
Page, Mark ;
Raddi, Gianmarco ;
Baxendale, Helen ;
Castillo-Olivares, Javier ;
Heeney, Jonathan ;
Temperton, Nigel .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[4]   Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases [J].
Castillo-Olivares, Javier ;
Wells, David A. ;
Ferrari, Matteo ;
Chan, Andrew C. Y. ;
Smith, Peter ;
Nadesalingam, Angalee ;
Paloniemi, Minna ;
Carnell, George W. ;
Ohlendorf, Luis ;
Cantoni, Diego ;
Mayora-Neto, Martin ;
Palmer, Phil ;
Tonks, Paul ;
Temperton, Nigel J. ;
Peterhoff, David ;
Neckermann, Patrick ;
Wagner, Ralf ;
Doffinger, Rainer ;
Kempster, Sarah ;
Otter, Ashley D. ;
Semper, Amanda ;
Brooks, Tim ;
Albecka, Anna ;
James, Leo C. ;
Page, Mark ;
Schwaeble, Wilhelm ;
Baxendale, Helen ;
Heeney, Jonathan L. .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[5]   Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis [J].
Cromer, Deborah ;
Steain, Megan ;
Reynaldi, Arnold ;
Schlub, Timothy E. ;
Wheatley, Adam K. ;
Juno, Jennifer A. ;
Kent, Stephen J. ;
Triccas, James A. ;
Khoury, David S. ;
Davenport, Miles P. .
LANCET MICROBE, 2022, 3 (01) :E52-E61
[6]   Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection [J].
Feng, Shuo ;
Phillips, Daniel J. ;
White, Thomas ;
Sayal, Homesh ;
Aley, Parvinder K. ;
Bibi, Sagida ;
Dold, Christina ;
Fuskova, Michelle ;
Gilbert, Sarah C. ;
Hirsch, Ian ;
Humphries, Holly E. ;
Jepson, Brett ;
Kelly, Elizabeth J. ;
Plested, Emma ;
Shoemaker, Kathryn ;
Thomas, Kelly M. ;
Vekemans, Johan ;
Villafana, Tonya L. ;
Lambe, Teresa ;
Pollard, Andrew J. ;
Voysey, Merryn .
NATURE MEDICINE, 2021, 27 (11) :2032-+
[7]   Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection [J].
Gharbharan, Arvind ;
Jordans, Carlijn C. E. ;
GeurtsvanKessel, Corine ;
den Hollander, Jan G. ;
Karim, Faiz ;
Mollema, Femke P. N. ;
Stalenhoef-Schukken, Janneke E. ;
Dofferhoff, Anthonius ;
Ludwig, Inge ;
Koster, Adrianus ;
Hassing, Robert-Jan ;
Bos, Jeannet C. ;
van Pottelberge, Geert R. ;
Vlasveld, Imro N. ;
Ammerlaan, Heidi S. M. ;
Leeuwen-Segarceanu, Elena M. van ;
Miedema, Jelle ;
van der Eerden, Menno ;
Schrama, Thijs J. ;
Papageorgiou, Grigorios ;
te Boekhorst, Peter ;
Swaneveld, Francis H. ;
Mueller, Yvonne M. ;
Schreurs, Marco W. J. ;
van Kampen, Jeroen J. A. ;
Rockx, Barry ;
Okba, Nisreen M. A. ;
Katsikis, Peter D. ;
Koopmans, Marion P. G. ;
Haagmans, Bart L. ;
Rokx, Casper ;
Rijnders, Bart J. A. .
NATURE COMMUNICATIONS, 2021, 12 (01)
[8]   Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab [J].
Gupta, Anil ;
Gonzalez-Rojas, Yaneicy ;
Juarez, Erick ;
Casal, Manuel Crespo ;
Moya, Jaynier ;
Falci, Diego R. ;
Sarkis, Elias ;
Solis, Joel ;
Zheng, Hanzhe ;
Scott, Nicola ;
Cathcart, Andrea L. ;
Hebner, Christy M. ;
Sager, Jennifer ;
Mogalian, Erik ;
Tipple, Craig ;
Peppercorn, Amanda ;
Alexander, Elizabeth ;
Pang, Phillip S. ;
Free, Almena ;
Brinson, Cynthia ;
Aldinger, Melissa ;
Shapiro, Adrienne E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (21) :1941-1950
[9]   Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection [J].
Hall, Victoria ;
Foulkes, Sarah ;
Insalata, Ferdinando ;
Kirwan, Peter ;
Saei, Ayoub ;
Atti, Ana ;
Wellington, Edgar ;
Khawam, Jameel ;
Munro, Katie ;
Cole, Michelle ;
Tranquillini, Caio ;
Taylor-Kerr, Andrew ;
Hettiarachchi, Nipunadi ;
Calbraith, Davina ;
Sajedi, Noshin ;
Milligan, Iain ;
Themistocleous, Yrene ;
Corrigan, Diane ;
Cromey, Lisa ;
Price, Lesley ;
Stewart, Sally ;
de Lacy, Elen ;
Norman, Chris ;
Linley, Ezra ;
Otter, Ashley D. ;
Semper, Amanda ;
Hewson, Jacqueline ;
D'Arcangelo, Silvia ;
Chand, Meera ;
Brown, Colin S. ;
Brooks, Tim ;
Islam, Jasmin ;
Charlett, Andre ;
Hopkins, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13) :1207-1220
[10]   SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) [J].
Hall, Victoria Jane ;
Foulkes, Sarah ;
Charlett, Andre ;
Atti, Ana ;
Monk, Edward J. M. ;
Simmons, Ruth ;
Wellington, Edgar ;
Cole, Michelle J. ;
Saei, Ayoub ;
Oguti, Blanche ;
Munro, Katie ;
Wallace, Sarah ;
Kirwan, Peter D. ;
Shrotri, Madhumita ;
Vusirikala, Amoolya ;
Rokadiya, Sakib ;
Kall, Meaghan ;
Zambon, Maria ;
Ramsay, Mary ;
Brooks, Tim ;
Brown, Colin S. ;
Chand, Meera A. ;
Hopkins, Susan .
LANCET, 2021, 397 (10283) :1459-1469